- Home
- IPST vs MCRB Comparison
IPST vs MCRB Comparison
Compare IPST & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPST
- MCRB
- Stock Information
- Founded
- IPST 2011
- MCRB 2010
- Country
- IPST United States
- MCRB United States
- Employees
- IPST N/A
- MCRB N/A
- Industry
- IPST Beverages (Production/Distribution)
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- IPST Consumer Staples
- MCRB Health Care
- Exchange
- IPST Nasdaq
- MCRB Nasdaq
- Market Cap
- IPST 163.4M
- MCRB 144.6M
- IPO Year
- IPST 2024
- MCRB 2015
- Fundamental
- Price
- IPST $0.63
- MCRB $17.84
- Analyst Decision
- IPST
- MCRB Hold
- Analyst Count
- IPST 0
- MCRB 4
- Target Price
- IPST N/A
- MCRB $14.33
- AVG Volume (30 Days)
- IPST 445.4K
- MCRB 102.0K
- Earning Date
- IPST 11-25-2025
- MCRB 11-12-2025
- Dividend Yield
- IPST N/A
- MCRB N/A
- EPS Growth
- IPST N/A
- MCRB N/A
- EPS
- IPST N/A
- MCRB 10.22
- Revenue
- IPST $7,058,550.00
- MCRB N/A
- Revenue This Year
- IPST N/A
- MCRB N/A
- Revenue Next Year
- IPST N/A
- MCRB N/A
- P/E Ratio
- IPST N/A
- MCRB $1.74
- Revenue Growth
- IPST N/A
- MCRB N/A
- 52 Week Low
- IPST $0.27
- MCRB $6.53
- 52 Week High
- IPST $4.00
- MCRB $24.67
- Technical
- Relative Strength Index (RSI)
- IPST N/A
- MCRB 42.90
- Support Level
- IPST N/A
- MCRB $17.63
- Resistance Level
- IPST N/A
- MCRB $19.30
- Average True Range (ATR)
- IPST 0.00
- MCRB 1.13
- MACD
- IPST 0.00
- MCRB -0.30
- Stochastic Oscillator
- IPST 0.00
- MCRB 9.25
About IPST Heritage Distilling Holding Company Inc. Common Stock
Heritage Distilling Holding Co Inc is a craft distiller producing, marketing, and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon, and by shipping directly to consumers online, where legal. Currently, it sells products in the Pacific Northwest with limited distribution in other states throughout the U.S.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.